BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

BioInvest

Samsung Biologics Reports Fourth Quarter & Fiscal Year 2021 Financial Results

Q4'21 revenue of KRW 444.3 billion increased 18% compared to Q4'20. Q4'21 operating profit of KRW 128.8 billion increased 39% compar...

January 25, 2022 | News

Liminal BioSciences Announces Strategic Priorities for 2022

"2021 has been an important year for us: we have simplified our business strategy and created a liquidity reserve that will allow us to focus our resources...

January 24, 2022 | News

ReviR Therapeutics Raises ~$20M in Pre-A Financing

The funds will be used to advance the company's voyageR™ discovery platform, which integrates machine learning and RNA exploration at scale to i...

January 18, 2022 | News

Cellusion Raises 1.1B JPY to Advance Japan and Global Clinical Trials

Cellusion Inc., a regenerative medicine startup aiming to solve the global Corneal transplant waiting list problem with a unique differentiation induction ...

January 10, 2022 | News

Virtue Diagnostics closes $100 million Series B Funding

Virtue Diagnostics is a global, platform-based IVD (In Vitro Diagnostic) company focusing on providing affordable clinical solutions at all disease stages ...

January 06, 2022 | News

Novo Nordisk Announces Completion of Dicerna Pharmaceuticals Acquisition

Following the expiration of Novo Nordisk’s cash tender offer for Dicerna, Novo Nordisk has today acquired all outstanding shares of common stock of D...

December 29, 2021 | News

Syntach AB awarded an EU grant of € 2.5 million

Over 60 million people suffer from heart failure, and it is one of the most common causes of death globally. A cardiac support system can prolong and save ...

December 21, 2021 | News

Alembic Pharma announces seed round investment in RIGImmune

India based Alembic Pharmaceuticals has made a strategic investment in RIGImmune, a biopharmaceutical research company co-founded by two prominent Yale Uni...

December 13, 2021 | Opinion

Merck announced the expansion of its strategic, corporate venture capital arm M Ventures.

Merck, a leading science and technology company, today announced the expansion of its strategic, corporate venture capital arm M Ventures. The new investme...

December 09, 2021 | News

Novalis LifeSciences has raised $300M in capital for its second fund

Novalis LifeSciences LLC, an investment and advisory firm for the Life Science industry, announced today that is has raised $300M in capital for ...

December 09, 2021 | News

Sartorius grows operations in France and is investing 100 million euros by 2025

The site in Aubagne, Sartorius’ headquarters in France, will receive the major part of this investment to build new cleanrooms and R&D laborato...

November 29, 2021 | News

Neurophth Raised Over $60 Million USD in Series-C Financing to Advance Gene Therapies

Additional new investors include funds and accounts managed by Sunshine Insurance and China Merchant Bank International Capital. To support Neurophth's rap...

November 24, 2021 | News

EQT Infrastructure to acquire Icon Group, Australia's largest integrated cancer care provider

Icon Group is Australia's largest vertically integrated cancer care provider, offering radiation oncology, medical oncology, compounding an...

November 19, 2021 | News

$5M Boost to Innovation in Australia with New Illumina Genomics Lab

Illumina, Inc. (NASDAQ: ILMN), the global leader in genomics, today announced the opening of a new, fully equipped laboratory to help Australian researcher...

November 15, 2021 | News

Stay Connected